Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 29316 | 154 | 23.8 | 61% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 3918 | 514 | CICLETANINE//TIROPRAMIDE//MUSANGA CECROPIOIDES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CICLETANINE | Author keyword | 106 | 82% | 40% | 61 |
| 2 | CA 2 ACTIVATED POTASSIUM CHANNEL | Author keyword | 1 | 50% | 1% | 1 |
| 3 | ELECTROTONIC PROPAGATION | Author keyword | 1 | 50% | 1% | 1 |
| 4 | FREQUENCY LOADING | Author keyword | 1 | 50% | 1% | 1 |
| 5 | FUROPYRIDINE DERIVATIVES | Author keyword | 1 | 50% | 1% | 1 |
| 6 | GLOMERULAR EFFECTS | Author keyword | 1 | 50% | 1% | 1 |
| 7 | HUMAN EPIGASTRIC ARTERIES | Author keyword | 1 | 50% | 1% | 1 |
| 8 | NACL SENSITIVE HYPERTENSION | Author keyword | 1 | 50% | 1% | 1 |
| 9 | PERFUSED MESENTERIC ARTERY | Author keyword | 1 | 50% | 1% | 1 |
| 10 | CELL GROWTH FACTORS | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SHR SP | 6 | 100% | 3% | 4 |
| 2 | PIG RESISTANCE ARTERIES | 2 | 67% | 1% | 2 |
| 3 | ION SHIFTS | 1 | 22% | 3% | 4 |
| 4 | ARTERY OCCLUSION REPERFUSION | 1 | 50% | 1% | 1 |
| 5 | BASELINE MEASUREMENTS | 1 | 50% | 1% | 1 |
| 6 | ELECTRO PHYSIOLOGICAL CHANGES | 1 | 50% | 1% | 1 |
| 7 | CICLETANINE | 1 | 16% | 2% | 3 |
| 8 | TUBULAR SITE | 0 | 33% | 1% | 1 |
| 9 | ISCHEMIC VENTRICULAR ARRHYTHMIAS | 0 | 25% | 1% | 1 |
| 10 | 6 KETO PGF1 ALPHA | 0 | 20% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Cicletanine - New insights into its pharmacological actions | 1999 | 7 | 53 | 83% |
| REVIEW OF 3 STUDIES TO DETERMINE THE EFFICACY AND TOLERANCE OF CICLETANINE IN THE SHORT-TERM AND LONG-TERM TREATMENT OF ESSENTIAL-HYPERTENSION | 1988 | 18 | 2 | 100% |
| EFFICACY AND TOLERANCE OF CICLETANINE, A NEW ANTIHYPERTENSIVE AGENT - OVERVIEW OF 1226 TREATED PATIENTS | 1988 | 14 | 7 | 100% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SECT INTERNAL MED DISABIL PREVENT | 0 | 13% | 1.3% | 2 |
| 2 | SERV PHARMACOL MED | 0 | 11% | 0.6% | 1 |
| 3 | EA 13S | 0 | 100% | 0.6% | 1 |
| 4 | SERV PHARMACOL PHARMACOCINET | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000203084 | TIROPRAMIDE//MUSANGA CECROPIOIDES//MUSEUM NAT MED |
| 2 | 0.0000172301 | INDAPAMIDE//CLIN NUTR METAB DIS//PHARMACOL PHYSIOPATHOL CARDIOVASC |
| 3 | 0.0000096956 | PRACTICE POINTS//RENAL PROSTANOIDS//PAH CLEARANCE |
| 4 | 0.0000082971 | ANIPAMIL//KINGS CARDIOVASC BIOL MED//S 2150 |
| 5 | 0.0000064980 | CEFROXADINE//ABSCESS PENETRATION//RADICULAR GRANULOMA |
| 6 | 0.0000063867 | MOLSIDOMINE//CLIN INTERNAL DIS 3//LINSIDOMINE |
| 7 | 0.0000062697 | CASIMIROA EDULIS//CASIMIROA PUBESCENS//CASIMIROA PRINGLEI |
| 8 | 0.0000060319 | POSTGANGLIONIC PULMONARY SYMPATHETIC DISCHARGE//MED HLTH SCI PHYSIOL//EXPERIMENTAL PULMONARY EMBOLISM |
| 9 | 0.0000060049 | FELODIPINE//NORMOTENSIVE VOLUNTEERS//ARANIDIPINE |
| 10 | 0.0000056401 | ANOREXIGENIC PEPTIDE//CYANIDE ADDITION//5 RAPID AMPLIFICATION OF CDNA ENDS |